knowledge -WSS

knowledge

author：knowledge 2025-09-28 02:32:56 - browse：8699

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Israel withdraws forces after 2

knowledge

WSS

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

'Ancient DNA,' 23andMe reveal African American ancestries

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

The leaders of Italy and Poland say European Union should focus on stopping migration

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

hotspot

knowledge

focus

At least 13 dead in Texas as scorching temps continue

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

23andMe had bad news about my health. I wish a person had delivered it

ProMED, early warning system on disease outbreaks, in peril

BioMarin wins approval for gene therapy to treat hemophilia A

A cyberattack has disrupted hospitals and health care in several states

What does generative AI mean for health care? We asked experts

What Henrietta Lacks settlement says about racism in medicine

State Dept. review finds Biden bears some blame for Afghanistan failures

Microsoft strikes partnership with Duke Health to advance health AI

entertainment

5 shark bites reported on Long Island as officials deploy surveillance drones

Adele warns fans about throwing things at performers onstage

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

My superpower is killing ticks

What the cancer research community can learn from the Covid response

For BCIs, commercial hurdles may be bigger than scientific ones

leisure time

knowledge

focus

Wikipedia